Heds acyclovir trifluridine

Both of these agents are FDA approved for treating HSVK. We noted a different practice prevalent among our ophthalmologists; 45

2024-03-29
    Tri-levlen discontinued
  1. Poirer RH
  2. Topical trifluridine
  3. Penny A
  4. The choice of agent will
  5. Mapcarta, the open map
  6. 9 Commonly, the same virus is associated with the recurrent episodes
  7. Purpose of the HEDS I study
  8. 89 No significant benefit for oral acyclovir